Siblings Papers [0/1] Patents [0/20] Collection Statistics Item counts issued in 3 years:1(3.23%) Items With Fulltext:31(100.00%) Download counts of the item Download times greater than 0:31(100.00%) Download times greater than 100:31(100.00%) Total Bitstream Download Counts:25984(100.00%) Last Update: 2024-12-11 17:14 Top Upload Loading... Top Download Loading... Recent Submissions Rosmarinic acid interferes with inf... Rosmarinic acid exhibits broad anti... A novel flavivirus entry inhibitor,... A novel, potent, and orally bioavai... Development of robust genotype 1a h... Mutagenesis of dengue virus protein... A potent, selective, and orally bio... Stimulatory actions of a novel thio... In vitro and in vivo studies of a p... A novel dengue virus inhibitor, BP1...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 31. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2022-08	Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels	Journal of Microbiology, Immunology, and Infection. 2022 Aug;55(4):598-610.
2020-12	Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
2019-12	A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses	Antiviral Research. 2019 Dec;172:Article number 104636.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2018-09	Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication	Journal of Virological Methods. 2018 Sep;259:10-17.
2017-12	Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels	Journal of Cellular Physiology. 2017 Dec;232(12):3409-3421.
2017-06	Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments	Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2016-07	In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71	Journal of Antimicrobial Chemotherapy. 2016 Jul;71(7):1922-1932.
2014-01	A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease	Antimicrobial Agents and Chemotherapy. 2014 Jan;58(1):110-119.

Showing items 1-10 of 31. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page